Tomasz Sliwinski

Support for Planning of Mobile Personnel Tasks by Solving Time-Dependent Routing Problems

Mariusz Kaleta, Włodzimierz Ogryczak, Piotr Pałka, 2016 .

Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile.

Curt I Civin, Kara Scheibner, Tomasz Sliwinski, 2013, Blood.

PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas

Reinhard Dummer, Kinga Majchrzak, Tomasz Sliwinski, 2016, Oncotarget.

Tyrosine kinase blockers: new hope for successful cancer therapy.

Deborah Ferriola, Tomasz Poplawski, Tomasz Sliwinski, 2009, Anti-cancer agents in medicinal chemistry.